Immune checkpoint inhibitor-based therapy in gynecologic clear cell carcinoma: A systematic review and meta-analysis
Introduction: Gynecologic clear cell carcinoma (CCC) is an uncommon histologic entity for which therapeutic options remain limited, and the clinical activity of immune checkpoint inhibitor (ICI)-based treatment has not been clearly defined. Objective: To synthesize the available evidence on efficacy and safety of ICI-c...